Literature DB >> 29516026

FACS-based Isolation of Neural and Glioma Stem Cell Populations from Fresh Human Tissues Utilizing EGF Ligand.

Jessica Tome-Garcia1,2, Fiona Doetsch3, Nadejda M Tsankova1,2.   

Abstract

Direct isolation of human neural and glioma stem cells from fresh tissues permits their biological study without prior culture and may capture novel aspects of their molecular phenotype in their native state. Recently, we demonstrated the ability to prospectively isolate stem cell populations from fresh human germinal matrix and glioblastoma samples, exploiting the ability of cells to bind the Epidermal Growth Factor (EGF) ligand in fluorescence-activated cell sorting (FACS). We demonstrated that FACS-isolated EGF-bound neural and glioblastoma populations encompass the sphere-forming colonies in vitro, and are capable of both self-renewal and multilineage differentiation. Here we describe in detail the purification methodology of EGF-bound (i.e., EGFR+) human neural and glioma cells with stem cell properties from fresh postmortem and surgical tissues. The ability to prospectively isolate stem cell populations using native ligand-binding ability opens new doors for understanding both normal and tumor cell biology in uncultured conditions, and is applicable for various downstream molecular sequencing studies at both population and single-cell resolution.

Entities:  

Keywords:  EGF; EGFR; FACS; Germinal matrix; Glioblastoma; Human; Neural; Stem cells

Year:  2017        PMID: 29516026      PMCID: PMC5836493          DOI: 10.21769/BioProtoc.2659

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  25 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

Review 2.  The interface between glial progenitors and gliomas.

Authors:  Peter Canoll; James E Goldman
Journal:  Acta Neuropathol       Date:  2008-09-11       Impact factor: 17.088

3.  The somatic genomic landscape of glioblastoma.

Authors:  Cameron W Brennan; Roel G W Verhaak; Aaron McKenna; Benito Campos; Houtan Noushmehr; Sofie R Salama; Siyuan Zheng; Debyani Chakravarty; J Zachary Sanborn; Samuel H Berman; Rameen Beroukhim; Brady Bernard; Chang-Jiun Wu; Giannicola Genovese; Ilya Shmulevich; Jill Barnholtz-Sloan; Lihua Zou; Rahulsimham Vegesna; Sachet A Shukla; Giovanni Ciriello; W K Yung; Wei Zhang; Carrie Sougnez; Tom Mikkelsen; Kenneth Aldape; Darell D Bigner; Erwin G Van Meir; Michael Prados; Andrew Sloan; Keith L Black; Jennifer Eschbacher; Gaetano Finocchiaro; William Friedman; David W Andrews; Abhijit Guha; Mary Iacocca; Brian P O'Neill; Greg Foltz; Jerome Myers; Daniel J Weisenberger; Robert Penny; Raju Kucherlapati; Charles M Perou; D Neil Hayes; Richard Gibbs; Marco Marra; Gordon B Mills; Eric Lander; Paul Spellman; Richard Wilson; Chris Sander; John Weinstein; Matthew Meyerson; Stacey Gabriel; Peter W Laird; David Haussler; Gad Getz; Lynda Chin
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

4.  Prospective isolation of late development multipotent precursors whose migration is promoted by EGFR.

Authors:  Francesca Ciccolini; Claudia Mandl; Gabriele Hölzl-Wenig; Angelika Kehlenbach; Andrea Hellwig
Journal:  Dev Biol       Date:  2005-08-01       Impact factor: 3.582

5.  Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis.

Authors:  Stefania Mazzoleni; Letterio S Politi; Mauro Pala; Manuela Cominelli; Alberto Franzin; Lucia Sergi Sergi; Andrea Falini; Michele De Palma; Alessandro Bulfone; Pietro L Poliani; Rossella Galli
Journal:  Cancer Res       Date:  2010-09-21       Impact factor: 12.701

6.  Eyes wide open: a critical review of sphere-formation as an assay for stem cells.

Authors:  Erika Pastrana; Violeta Silva-Vargas; Fiona Doetsch
Journal:  Cell Stem Cell       Date:  2011-05-06       Impact factor: 24.633

7.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.

Authors:  Jian Wang; Per Ø Sakariassen; Oleg Tsinkalovsky; Heike Immervoll; Stig Ove Bøe; Agnete Svendsen; Lars Prestegarden; Gro Røsland; Frits Thorsen; Linda Stuhr; Anders Molven; Rolf Bjerkvig; Per Ø Enger
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396

Review 8.  Advances in genetic and epigenetic analyses of gliomas: a neuropathological perspective.

Authors:  Nadejda M Tsankova; Peter Canoll
Journal:  J Neurooncol       Date:  2014-06-25       Impact factor: 4.130

9.  SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma.

Authors:  Myung Jin Son; Kevin Woolard; Do-Hyun Nam; Jeongwu Lee; Howard A Fine
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

10.  Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties.

Authors:  Jessica Tome-Garcia; Rut Tejero; German Nudelman; Raymund L Yong; Robert Sebra; Huaien Wang; Mary Fowkes; Margret Magid; Martin Walsh; Violeta Silva-Vargas; Elena Zaslavsky; Roland H Friedel; Fiona Doetsch; Nadejda M Tsankova
Journal:  Stem Cell Reports       Date:  2017-04-20       Impact factor: 7.765

View more
  2 in total

1.  Analysis of chromatin accessibility uncovers TEAD1 as a regulator of migration in human glioblastoma.

Authors:  Jessica Tome-Garcia; Parsa Erfani; German Nudelman; Alexander M Tsankov; Igor Katsyv; Rut Tejero; Martin Walsh; Roland H Friedel; Elena Zaslavsky; Nadejda M Tsankova
Journal:  Nat Commun       Date:  2018-10-01       Impact factor: 14.919

Review 2.  Role of dimethyl fumarate in the treatment of glioblastoma multiforme: A review article.

Authors:  Reza Ahmadi-Beni; Ali Najafi; Seyed Mehrdad Savar; Niayesh Mohebbi; Alireza Khoshnevisan
Journal:  Iran J Neurol       Date:  2019-07-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.